Authors: | Huang, J.; Detterbeck, F. C.; Wang, Z.; Loehrer, P. J. |
Article Title: | Standard outcome measures for thymic malignancies |
Abstract: | Thymic malignancies present particular issues due to the pace of disease progression, patterns of recurrence, and causes of death that make nuances of how outcomes are reported particularly important. The relatively limited number of patients also creates a challenge to glean as much as possible from the available experience, but risks over-interpretation and potentially misleading conclusions. Therefore the International Thymic Malignancy Interest Group has developed a set of standards for reporting of outcome measures of clinical studies, which have been adopted for collaborative projects undertaken by the organization. Widespread adoption of this baseline will enhance the ability to compare results from different series. Copyright © 2010 by the International Association for the Study of Lung Cancer. |
Keywords: | cancer chemotherapy; treatment response; overall survival; prednisone; disease course; cancer recurrence; cancer radiotherapy; disease free survival; cancer staging; outcome assessment; positron emission tomography; antineoplastic agent; computer assisted tomography; statistics; lung resection; recurrence; risk assessment; cause of death; cancer specific survival; medical society; cancer classification; thymoma; outcomes; disease specific survival; thymic carcinoma; thymus cancer; cause specific survival; sample size; mediastinal disease; disease related survival; international thymic malignancy interest group |
Journal Title: | Journal of Thoracic Oncology |
Volume: | 5 |
Issue: | 12 |
ISSN: | 1556-0864 |
Publisher: | Elsevier Inc. |
Date Published: | 2010-12-01 |
Start Page: | 2017 |
End Page: | 2023 |
Language: | English |
DOI: | 10.1097/JTO.0b013e3181f13682 |
PROVIDER: | scopus |
PUBMED: | 20978450 |
DOI/URL: | |
Notes: | --- - "Export Date: 20 April 2011" - "Source: Scopus" |